Sonoda, Junichiro <br/><br/>
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases.  [electronic resource] 

 -  Hormone molecular biology and clinical investigation  May 2017 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1868-1891 
<br/><br/><label>Standard No.: </label>10.1515/hmbci-2017-0002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Energy Metabolism--drug effects<br/>Fibroblast Growth Factors--metabolism<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Obesity--drug therapy<br/>Protein Stability<br/>Receptor, Fibroblast Growth Factor, Type 1--agonists<br/>Signal Transduction--drug effects<br/>Transcription, Genetic